Sargon II (reigned 722-705 BCE) was one of the most important kings of the Neo-Assyrian Empire as founder of the Sargonid Dynasty which would rule the empire for the next century until its fall. He was a great military leader, tactician, patron of the arts and culture, and a prolific builder of monuments, temples, and even a city.
Harvoni can be used by people being treated for hepatitis C for the first time (known as âtreatment-naiveâ) and for retreatment of people who were not cured with previous interferon-based therapy (known as âtreatment-experiencedâ). Harvoni has also been tested in people with HIV and HCV co-infection.
The researchers estimated that 1.6 million people will be eligible for hep C treatment during the next five years. Paying for all their treatment would cost insurers $136 billion, a figure that is $65 billion higher than treating with the older drug regimens. Treating with the new, more effective Harvoni would save $16 billion in drug costs. The study assumed that Harvoni costs insurers $1,125 per day, the set price for the single-tablet therapy. However, in recent months various pharmacy benefit managers have secured discounts for Harvoni, which may improve the outlook both in terms of cost-effectiveness and overall cost burden.